Skip to content
Screener

Pulse Biosciences, Inc. PLSE Q2 2025 earnings

Reported August 12, 2025 · After market close

Revenue-
EPS-$0.28Miss by $0.02
EPS estimate-$0.26

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$620.0K
EPS estimate-$0.35

Financials

Q2 2025

Income statement

See full
Revenue-—
Gross profit-—
Operating income-$20.3M-72.9%
Net income-$19.2M-68.4%

Balance sheet

See full
Cash & equivalents$106.3M+306%
Total debt$8.2M-4.6%
Total equity$104.5M+287%
Total assets$120.3M+197%

Cash flow

See full
Operating cash flow-$12.8M-52.6%
CapEx$103.0K+255%
Free cash flow-$12.9M-53.3%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$1.04B+67.8%
Enterprise value$937.91M+56.4%

Returns & leverage

See full
Return on equity-103.5%+3.0pp
Debt / equity0.1×-0.2×
Current ratio12×+7.5×

Segments

By segment

See full
Single Reportable-—

FAQ

When did Pulse Biosciences, Inc. report Q2 2025 earnings?
Pulse Biosciences, Inc. (PLSE) reported Q2 2025 earnings on August 12, 2025 after market close.
What were Pulse Biosciences, Inc.'s Q2 2025 revenue and EPS?
Pulse Biosciences, Inc. reported revenue of - and eps of $-0.28 for Q2 2025.
Did Pulse Biosciences, Inc. beat estimates in Q2 2025?
EPS missed the consensus estimate of $-0.26 by $0.02.
How did Pulse Biosciences, Inc.'s Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 40.7% from $-0.20.
Where can I find Pulse Biosciences, Inc.'s Q2 2025 SEC filings?
You can read the 8-K earnings release (0001437749-25-026195) and the 10-Q periodic report (0001437749-25-026209) directly on SEC EDGAR. The filing index links above go to sec.gov.